• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Probing the interaction between cHAVc3 peptide and the EC1 domain of E-cadherin using NMR and molecular dynamics simulations.利用核磁共振(NMR)和分子动力学模拟探究cHAVc3肽与E-钙黏蛋白EC1结构域之间的相互作用。
J Biomol Struct Dyn. 2017 Jan;35(1):92-104. doi: 10.1080/07391102.2015.1133321. Epub 2016 Apr 12.
2
Comparison of Linear and Cyclic His-Ala-Val Peptides in Modulating the Blood-Brain Barrier Permeability: Impact on Delivery of Molecules to the Brain.线性与环状组氨酸-丙氨酸-缬氨酸肽对血脑屏障通透性调节作用的比较:对分子向脑内递送的影响
J Pharm Sci. 2016 Feb;105(2):797-807. doi: 10.1016/S0022-3549(15)00188-4.
3
Mechanism of the blood-brain barrier modulation by cadherin peptides.钙黏蛋白肽调节血脑屏障的机制。
Explor Drug Sci. 2024;2(3):322-338. doi: 10.37349/eds.2024.00049. Epub 2024 Jun 26.
4
(1)H, (13)C and (15)N backbone assignment of the EC-1 domain of human E-cadherin.人E-钙黏蛋白EC-1结构域的(1)H、(13)C和(15)N主链归属
Biomol NMR Assign. 2015 Apr;9(1):31-5. doi: 10.1007/s12104-013-9539-6. Epub 2014 Feb 8.
5
A cyclic peptide inhibitor of apoC-II peptide fibril formation: mechanistic insight from NMR and molecular dynamics analysis.载脂蛋白 C-II 肽纤维形成的环状肽抑制剂:来自 NMR 和分子动力学分析的机制见解。
J Mol Biol. 2012 Mar 9;416(5):642-55. doi: 10.1016/j.jmb.2011.12.059. Epub 2012 Jan 5.
6
Exploring E-cadherin-peptidomimetics interaction using NMR and computational studies.利用 NMR 和计算研究探索 E-钙黏蛋白肽模拟物的相互作用。
PLoS Comput Biol. 2019 Jun 3;15(6):e1007041. doi: 10.1371/journal.pcbi.1007041. eCollection 2019 Jun.
7
Improving the selectivity of HAV-peptides in modulating E-cadherin-E-cadherin interactions in the intercellular junction of MDCK cell monolayers.提高甲型肝炎病毒肽在调节MDCK细胞单层细胞间连接中E-钙黏蛋白-E-钙黏蛋白相互作用方面的选择性。
Pharm Res. 2001 Apr;18(4):446-53. doi: 10.1023/a:1011094025008.
8
Solution structure and in silico binding of a cyclic peptide with hepatitis B surface antigen.乙型肝炎表面抗原环状肽的溶液结构与计算机模拟结合
Chem Biol Drug Des. 2013 Jun;81(6):784-94. doi: 10.1111/cbdd.12120.
9
Binding affinity difference induced by the stereochemistry of the sulfoxide bridge of the cyclic peptide inhibitors of Grb2-SH2 domain: NMR studies for the structural origin.Grb2-SH2结构域环肽抑制剂亚砜桥立体化学诱导的结合亲和力差异:结构起源的核磁共振研究
Biochem Biophys Res Commun. 2005 May 20;330(4):1254-61. doi: 10.1016/j.bbrc.2005.03.110.
10
Role of electrostatic interactions in binding of peptides and intrinsically disordered proteins to their folded targets. 1. NMR and MD characterization of the complex between the c-Crk N-SH3 domain and the peptide Sos.静电相互作用在肽和天然无序蛋白质与其折叠靶标结合中的作用。1. c-Crk N-SH3 结构域与 Sos 肽复合物的 NMR 和 MD 表征。
Biochemistry. 2014 Oct 21;53(41):6473-95. doi: 10.1021/bi500904f. Epub 2014 Oct 7.

引用本文的文献

1
Mechanism of the blood-brain barrier modulation by cadherin peptides.钙黏蛋白肽调节血脑屏障的机制。
Explor Drug Sci. 2024;2(3):322-338. doi: 10.37349/eds.2024.00049. Epub 2024 Jun 26.
2
Exploring How Antibody Format Drives Clearance from the Brain.探索抗体形式如何影响大脑清除率。
Mol Pharm. 2024 Sep 2;21(9):4416-4429. doi: 10.1021/acs.molpharmaceut.4c00354. Epub 2024 Jul 26.
3
Mutations of SARS-CoV-2 RBD May Alter Its Molecular Structure to Improve Its Infection Efficiency.SARS-CoV-2 RBD 的突变可能会改变其分子结构,从而提高其感染效率。
Biomolecules. 2021 Aug 25;11(9):1273. doi: 10.3390/biom11091273.
4
Improving In Vivo Brain Delivery of Monoclonal Antibody Using Novel Cyclic Peptides.使用新型环肽改善单克隆抗体的体内脑递送
Pharmaceutics. 2019 Oct 31;11(11):568. doi: 10.3390/pharmaceutics11110568.
5
Brain Delivery and Brain Deposition of Proteins with Various Sizes.不同大小蛋白的脑内传递和脑内沉积。
Mol Pharm. 2019 Dec 2;16(12):4878-4889. doi: 10.1021/acs.molpharmaceut.9b00763. Epub 2019 Nov 12.
6
Improving Brain Delivery of Biomolecules via BBB Modulation in Mouse and Rat: Detection using MRI, NIRF, and Mass Spectrometry.通过调节小鼠和大鼠的血脑屏障改善生物分子向脑内的递送:使用磁共振成像、近红外荧光成像和质谱法进行检测。
Nanotheranostics. 2017;1(2):217-231. doi: 10.7150/ntno.19158. Epub 2017 Jun 8.

本文引用的文献

1
Comparison of Linear and Cyclic His-Ala-Val Peptides in Modulating the Blood-Brain Barrier Permeability: Impact on Delivery of Molecules to the Brain.线性与环状组氨酸-丙氨酸-缬氨酸肽对血脑屏障通透性调节作用的比较:对分子向脑内递送的影响
J Pharm Sci. 2016 Feb;105(2):797-807. doi: 10.1016/S0022-3549(15)00188-4.
2
GROMACS 4:  Algorithms for Highly Efficient, Load-Balanced, and Scalable Molecular Simulation.GROMACS 4:高效、负载均衡和可扩展的分子模拟算法。
J Chem Theory Comput. 2008 Mar;4(3):435-47. doi: 10.1021/ct700301q.
3
Modulation of intercellular junctions by cyclic-ADT peptides as a method to reversibly increase blood-brain barrier permeability.环化ADT肽对细胞间连接的调节作为一种可逆增加血脑屏障通透性的方法。
J Pharm Sci. 2015 Mar;104(3):1065-75. doi: 10.1002/jps.24309. Epub 2015 Jan 12.
4
Pathways and progress in improving drug delivery through the intestinal mucosa and blood-brain barriers.改善药物通过肠黏膜和血脑屏障递送的途径与进展。
Ther Deliv. 2014 Oct;5(10):1143-63. doi: 10.4155/tde.14.67.
5
(1)H, (13)C and (15)N backbone assignment of the EC-1 domain of human E-cadherin.人E-钙黏蛋白EC-1结构域的(1)H、(13)C和(15)N主链归属
Biomol NMR Assign. 2015 Apr;9(1):31-5. doi: 10.1007/s12104-013-9539-6. Epub 2014 Feb 8.
6
Modulation of blood-brain barrier permeability in mice using synthetic E-cadherin peptide.使用合成E-钙黏蛋白肽调节小鼠血脑屏障通透性
Mol Pharm. 2014 Mar 3;11(3):974-81. doi: 10.1021/mp400624v. Epub 2014 Feb 19.
7
Using chemical shift perturbation to characterise ligand binding.利用化学位移扰动来表征配体结合。
Prog Nucl Magn Reson Spectrosc. 2013 Aug;73:1-16. doi: 10.1016/j.pnmrs.2013.02.001. Epub 2013 Mar 21.
8
Improving the stability of the EC1 domain of E-cadherin by thiol alkylation of the cysteine residue.通过半胱氨酸残基的巯基烷基化来提高 E-钙黏蛋白 EC1 结构域的稳定性。
Int J Pharm. 2012 Jul 15;431(1-2):16-25. doi: 10.1016/j.ijpharm.2012.03.051. Epub 2012 Apr 17.
9
A peptidomimetic tight junction modulator to improve regional analgesia.一种模拟肽紧密连接调节剂,可改善区域镇痛。
Mol Pharm. 2012 Jun 4;9(6):1785-94. doi: 10.1021/mp3000937. Epub 2012 May 10.
10
Application of NMR and molecular docking in structure-based drug discovery.核磁共振(NMR)与分子对接在基于结构的药物发现中的应用。
Top Curr Chem. 2012;326:1-34. doi: 10.1007/128_2011_213.

利用核磁共振(NMR)和分子动力学模拟探究cHAVc3肽与E-钙黏蛋白EC1结构域之间的相互作用。

Probing the interaction between cHAVc3 peptide and the EC1 domain of E-cadherin using NMR and molecular dynamics simulations.

作者信息

Alaofi Ahmed, Farokhi Elinaz, Prasasty Vivitri D, Anbanandam Asokan, Kuczera Krzysztof, Siahaan Teruna J

机构信息

a Department of Pharmaceutical Chemistry , The University of Kansas , 2095 Constant Avenue, Lawrence , KS 66047 , USA.

d Faculty of Biotechnology , Atma Jaya Catholic University of Indonesia , Jakarta 12930 , Indonesia.

出版信息

J Biomol Struct Dyn. 2017 Jan;35(1):92-104. doi: 10.1080/07391102.2015.1133321. Epub 2016 Apr 12.

DOI:10.1080/07391102.2015.1133321
PMID:26728967
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5061580/
Abstract

The goal of this work is to probe the interaction between cyclic cHAVc3 peptide and the EC1 domain of human E-cadherin protein. Cyclic cHAVc3 peptide (cyclo(1,6)Ac-CSHAVC-NH) binds to the EC1 domain as shown by chemical shift perturbations in the 2D H,-N-HSQC NMR spectrum. The molecular dynamics (MD) simulations of the EC1 domain showed folding of the C-terminal tail region into the main head region of the EC1 domain. For cHAVc3 peptide, replica exchange molecular dynamics (REMD) simulations generated five structural clusters of cHAVc3 peptide. Representative structures of cHAVc3 and the EC1 structure from MD simulations were used in molecular docking experiments with NMR constraints to determine the binding site of the peptide on EC1. The results suggest that cHAVc3 binds to EC1 around residues Y36, S37, I38, I53, F77, S78, H79, and I94. The dissociation constants (K values) of cHAVc3 peptide to EC1 were estimated using the NMR chemical shifts data and the estimated Ks are in the range of .5 × 10-7.0 × 10 M.

摘要

这项工作的目标是探究环状cHAVc3肽与人E-钙黏蛋白的EC1结构域之间的相互作用。二维1H-N-HSQC NMR谱中的化学位移扰动表明,环状cHAVc3肽(环(1,6)Ac-CSHAVC-NH)与EC1结构域结合。EC1结构域的分子动力学(MD)模拟显示,C末端尾部区域折叠到EC1结构域的主要头部区域。对于cHAVc3肽,副本交换分子动力学(REMD)模拟生成了cHAVc3肽的五个结构簇。MD模拟得到的cHAVc3的代表性结构和EC1结构用于带有NMR约束的分子对接实验,以确定该肽在EC1上的结合位点。结果表明,cHAVc3在Y36、S37、I38、I53、F77、S78、H79和I94等残基周围与EC1结合。利用NMR化学位移数据估算了cHAVc3肽与EC1的解离常数(K值),估算的Ks在0.5×10⁻⁷ - 7.0×10⁻⁶ M范围内。